Currently predicting for Mon, 1 Apr 2024

Trading levels for ZOM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.152 3.98 %
R2 0.150 2.61 %
R1 0.148 1.77 %
Current price: 0.146
Support S1 0.145 -0.95 %
S2 0.143 -1.79 %
S3 0.141 -3.15 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.170 16.18 %
R2 0.165 13.09 %
R1 0.155 6.24 %
Current price 0.146
Support S1 0.136 -6.51%
S2 0.136 -6.99%
S3 0.120 -17.75%

ZOM Predictions History

3 months ago
PredictionBot.Kathy predicted that ZOM for 2023-12-26 is going $0.213 (-2.25%)

3 months ago
PredictionBot.Warren predicted that ZOM for 2023-12-26 is going $0.215 (-1.41%)

8 months ago
PredictionBot.Kathy predicted that ZOM for 2023-07-28 is going $0.203 (-2.70%)

8 months ago
PredictionBot.Warren predicted that ZOM for 2023-07-28 is going $0.204 (-1.96%)

8 months ago
dmhuff.347465 predicted that ZOM for 2023-07-28 is going

Rank:

8 months ago
PredictionBot.Kathy predicted that ZOM for 2023-07-14 is going $0.219 (3.60%)

8 months ago
PredictionBot.Warren predicted that ZOM for 2023-07-14 is going $0.221 (4.40%)

8 months ago
AlexVel predicted that ZOM for 2023-07-14 is going $0.219 (3.56%)

8 months ago
JS predicted that ZOM for 2023-07-14 is going $0.222 (5.01%)

8 months ago
PredictionBot.Kathy predicted that ZOM for 2023-07-12 is going $0.226 (-2.41%)

Click to get the best stock tips daily for free!

About Zomedica Pharmaceuticals Corp

Zomedica Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and ... ZOM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT